Literature DB >> 17943895

Interventions for the interruption or reduction of the spread of respiratory viruses.

T Jefferson, R Foxlee, C Del Mar, L Dooley, E Ferroni, B Hewak, A Prabhala, S Nair, A Rivetti.   

Abstract

BACKGROUND: Viral epidemics or pandemics such as of influenza or severe acute respiratory syndrome (SARS) pose a significant threat. Antiviral drugs and vaccination may not be adequate to prevent catastrophe in such an event.
OBJECTIVES: To systematically review the evidence of effectiveness of interventions to interrupt or reduce the spread of respiratory viruses (excluding vaccines and antiviral drugs, which have been previously reviewed). SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2006, Issue 4); MEDLINE (1966 to November 2006); OLDMEDLINE (1950 to 1965); EMBASE (1990 to November 2006); and CINAHL (1982 to November 2006). SELECTION CRITERIA: We scanned 2300 titles, excluded 2162 and retrieved the full papers of 138 trials, including 49 papers of 51 studies. The quality of three randomised controlled trials (RCTs) was poor; as were most cluster RCTs. The observational studies were of mixed quality. We were only able to meta-analyse case-control data. We searched for any interventions to prevent viral transmission of respiratory viruses (isolation, quarantine, social distancing, barriers, personal protection and hygiene). Study design included RCTs, cohort studies, case-control studies, cross-over studies, before-after, and time series studies. DATA COLLECTION AND ANALYSIS: We scanned the titles, abstracts and full text articles using a standardised form to assess eligibility. RCTs were assessed according to randomisation method, allocation generation, concealment, blinding, and follow up. Non-RCTs were assessed for the presence of potential confounders and classified as low, medium, and high risk of bias. MAIN
RESULTS: The highest quality cluster RCTs suggest respiratory virus spread can be prevented by hygienic measures around younger children. Additional benefit from reduced transmission from children to other household members is broadly supported in results of other study designs, where the potential for confounding is greater. The six case-control studies suggested that implementing barriers to transmission, isolation, and hygienic measures are effective at containing respiratory virus epidemics. We found limited evidence that the more uncomfortable and expensive N95 masks were superior to simple surgical masks. The incremental effect of adding virucidals or antiseptics to normal handwashing to decrease respiratory disease remains uncertain. The lack of proper evaluation of global measures such as screening at entry ports and social distancing prevent firm conclusions about these measures. AUTHORS'
CONCLUSIONS: Many simple and probably low-cost interventions would be useful for reducing the transmission of epidemic respiratory viruses. Routine long-term implementation of some of the measures assessed might be difficult without the threat of a looming epidemic.

Entities:  

Mesh:

Year:  2007        PMID: 17943895     DOI: 10.1002/14651858.CD006207.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  29 in total

1.  Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households.

Authors:  Elaine L Larson; Yu-hui Ferng; Jennifer Wong-McLoughlin; Shuang Wang; Michael Haber; Stephen S Morse
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

Review 2.  Prevention and control of infections in the home.

Authors:  John M Embil; Brenda Dyck; Pierre Plourde
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

3.  A primer on strategies for prevention and control of seasonal and pandemic influenza.

Authors:  Scott Santibañez; Anthony E Fiore; Toby L Merlin; Stephen Redd
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

4.  Who is conflicted about handwashing?

Authors:  B Lynn Johnston; Geoffrey Taylor; Mary Vearncombe; Bonnie Henry
Journal:  CMAJ       Date:  2009-11-24       Impact factor: 8.262

Review 5.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Sreekumaran Nair; Mark A Jones; Sarah Thorning; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

6.  Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.

Authors:  Jennifer Humberd Smith; Tamas Nagy; Jamie Barber; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

7.  Dispersion and exposure to a cough-generated aerosol in a simulated medical examination room.

Authors:  William G Lindsley; William P King; Robert E Thewlis; Jeffrey S Reynolds; Kedar Panday; Gang Cao; Jonathan V Szalajda
Journal:  J Occup Environ Hyg       Date:  2012       Impact factor: 2.155

8.  Modeling seasonal influenza outbreak in a closed college campus: impact of pre-season vaccination, in-season vaccination and holidays/breaks.

Authors:  Kristin L Nichol; Kate Tummers; Alanna Hoyer-Leitzel; Jennifer Marsh; Matt Moynihan; Steven McKelvey
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

9.  STOPFLU: is it possible to reduce the number of days off in office work by improved hand-hygiene?

Authors:  Carita Savolainen-Kopra; Jaason Haapakoski; Piia A Peltola; Thedi Ziegler; Terttu Korpela; Pirjo Anttila; Ali Amiryousefi; Pentti Huovinen; Markku Huvinen; Heikki Noronen; Pia Riikkala; Merja Roivainen; Petri Ruutu; Juha Teirilä; Erkki Vartiainen; Tapani Hovi
Journal:  Trials       Date:  2010-06-04       Impact factor: 2.279

10.  A novel anti-influenza copper oxide containing respiratory face mask.

Authors:  Gadi Borkow; Steve S Zhou; Tom Page; Jeffrey Gabbay
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.